Neumann Mark's Form 4 filing
Intra-Cellular Therapies, Inc. (ITCI) · filed Nov 8, 2023
- Accession no.
- 0001209191-23-054726
- Filed
- Nov 8, 2023
- Trade date
- Nov 6, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.36M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Neumann MarkCIK 0001756211 | Officer (EVP, Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 6, 2023 | Common Stock | MOption exerciseAcquired | +26,754 | $23.94 | +$640,490.76 | 72,093 | Direct | |
| Nov 6, 2023 | Common Stock | SSaleDisposed | −26,754 | $55.98 | −$1,497,688.92 | 45,339 | Direct | |
| Nov 6, 2023 | Common Stock | SSaleDisposed | −15,639 | $55.02 | −$860,457.78 | 29,700 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 6, 2023 | Common Stock | MOption exerciseDisposed | −26,754 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.